Details for New Drug Application (NDA): 208746
✉ Email this page to a colleague
The generic ingredient in PEMETREXED DITROMETHAMINE is pemetrexed ditromethamine. There are twenty-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pemetrexed ditromethamine profile page.
Summary for 208746
Tradename: | PEMETREXED DITROMETHAMINE |
Applicant: | Hospira |
Ingredient: | pemetrexed ditromethamine |
Patents: | 0 |
Pharmacology for NDA: 208746
Mechanism of Action | Folic Acid Metabolism Inhibitors |
Suppliers and Packaging for NDA: 208746
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PEMETREXED DITROMETHAMINE | pemetrexed ditromethamine | POWDER;INTRAVENOUS | 208746 | NDA | Hospira, Inc. | 0409-1060 | 0409-1060-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-1060-01) / 4.2 mL in 1 VIAL, SINGLE-DOSE |
PEMETREXED DITROMETHAMINE | pemetrexed ditromethamine | POWDER;INTRAVENOUS | 208746 | NDA | Hospira, Inc. | 0409-1061 | 0409-1061-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-1061-01) / 20 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | EQ 100MG BASE/VIAL | ||||
Approval Date: | Jun 10, 2022 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | EQ 500MG BASE/VIAL | ||||
Approval Date: | Jun 10, 2022 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;INTRAVENOUS | Strength | EQ 1GM BASE/VIAL | ||||
Approval Date: | Jun 10, 2022 | TE: | RLD: | Yes |
Complete Access Available with Subscription